Asia-Pacific tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 2.8% during the forecast period. Largest number of new TB cases was reported in Asia accounting for 45% of new cases. Tuberculosis incidence, and mortality rate was comparatively higher in countries with lower human development index, gross domestic product (GDP) per capita, corruption perception index and countries with more people under minimum food supplements. Among the health system variables, governmental health expenditure per capita, total health expenditure per capita, access to improved water, hospital beds and sanitation are strongly associated with tuberculosis. As Asia is the region with most of the developing countries, unavailability of these system variables increases the incidences of tuberculosis in the Asia-pacific.

Request a Free Sample of our Asia-Pacific Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/asia-pacific-tuberculosis-diagnosis-and-treatment-market

USAID has supported TB control and prevention in the Asia-Pacific region. Its major goal is the development as well as implementation of innovative and scalable programs for TB control in the Asia-Pacific region. The organization has been focusing on building comprehensive models to improve diagnosis, MDR-TB prevention, and treatment initiation, along with treatment success. USAID support strengthens national TB programs by assisting them and introducing innovative and cost-effective approaches to TB control. USAID along with countries government initiatives has been the major factor in the market growth.

A full Report of Asia-Pacific Tuberculosis Diagnosis and Treatment Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-tuberculosis-diagnosis-and-treatment-market

Asia-Pacific tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

Asia-Pacific Tuberculosis Diagnosis and Treatment Market Segmentation

By Drugs Type

• First Line Drugs
• Second Line Drugs

By Diagnosis

• Laboratory Testing
• Nucleic Acid Amplification Test
• Mantoux Test
• Radiography
• Drug Susceptibility Testing

Regional Analysis

• Asia-Pacific
• India
• Japan
• China
• Rest of Asia-Pacific

Company Profiles

• Abbott Laboratories
• Becton, Dickinson and Co.
• Biochemical and Synthetic Products Pvt Ltd.
• Eiken Chemical Co., Ltd.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline PLC
• Labatec Pharma SA
• Lupin Pharmaceuticals, Inc.
• Thermo Fisher Scientific

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-tuberculosis-diagnosis-and-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404